J Nephropathol. 2013;2(1): 4-5. doi: 10.5812/nephropathol.8966
PMID: 24475420        PMCID: PMC3886181

Editorial

Prediction of diabetic nephropathy: The need for a sweet biomarker


Cited by CrossRef: 7


1- Nasri H, Rafieian-Kopaei M. Garlic and Kidney Injury Protection. Shiraz E-Med J. 2013;14(4) [Crossref]
2- Baradaran A. Commentary on: effect of vitamin D on insulin resistance and anthropometric parameters in type 2 diabetes; a randomized double-blind clinical trial. DARU. 2013;21(1):19 [Crossref]
3- Nasri R. Renoprotective effects of metformin. DARU. 2013;21(1):36 [Crossref]
4- Coffey S, Costacou T, Orchard T, Erkan E, Dussaule J. Akt Links Insulin Signaling to Albumin Endocytosis in Proximal Tubule Epithelial Cells. PLoS ONE. 2015;10(10):e0140417 [Crossref]
5- Nasri H. Re Metformin revisited: A critical review of the benefit–risk balance in at-risk patients with type 2 diabetes. Diabetes & Metabolism. 2013;39(4):375 [Crossref]
6- Tolouian R, Vinik A. Nonblood/Urine Biomarker of Progression of Kidney Disease in Diabetes Mellitus. CJASN. 2015;10(7):1114 [Crossref]
7- Winter L, Wong L, Jerums G, Seah J, Clarke M, Tan S, Coughlan M, MacIsaac R, Ekinci E. Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease. Front Endocrinol. 2018;9 [Crossref]
8- Rafieian Kopaei M, Baradaran A. Protective Effects of Metformin on Renal Tubular Cells. Iran Red Crescent Med J. 2014;16(9) [Crossref]